Clicky

LEE S PHARMACEUTIC.HD-05(L1PA)

Description: Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China. It focuses on various disease areas, including cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates through Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells self-developed and generic pharmaceutical products, such as Nadroparin Calcium injection and Livaracine to treat blood clots and deep vein thrombosis; Yallaferon for viral infection; Slounase for hemostasis; Eyprotor for corneal ulcers; Treprostinil injection for pulmonary arterial hypertension; fondaparinux sodium injection for deep vein thrombosis; and Sodium Phenylbutyrate Granules to treat Urea cycle disorders. The Licensed-In Products segment trades in licensed-in pharmaceutical products, including Carnitene for the treatment of carnitine deficiency; Sancuso for chemotherapy induced nausea and vomiting; Bredinin to treat Immunosuppression in renal transplantation; Centraxal Plus for acute otitis media with tympanostomy tubes; Episil to treat oral mucositis pain; Ferplex to treat iron deficiency anemia; and Gaslon N for gastric ulcer and gastritis. This segment also offers Intrarosa for vulvovaginal atrophy; Adasuve for agitation associated with schizophrenia or bipolar I disorder in adults; Mictonorm for urinary incontinence; Natulan for Stage III and IV Hodgkin's disease; Omacor to treat Omega-3-acid ethyl esters; Zanidip and Rasilez for hypertension; Readyfusor for post-operative pain management; Teglutik to treat Amyotrophic lateral sclerosis; Trittico for insomnia/depression; Unidrox for urinary and respiratory tract infections; Dicoflor and VSL#3 for probiotics; and Zingo for topical local analgesics. The company was founded in 1994 and is headquartered in Sha Tin, Hong Kong.


Keywords: Pharmaceutical Products Disease Pain Medication Chemotherapy Rare Diseases Hypertension Pain Management Schizophrenia Transplantation Hematology Pulmonary Arterial Hypertension Nausea Hodgkin Urinary Incontinence Heparins Iron Deficiency Anemia Deep Vein Thrombosis Gastritis Blood Clots Oral Mucositis Treprostinil Urinary System Venous Thrombosis Viral Infection Gastric Ulcer Urea Cycle Disorders Sodium Phenylbutyrate Immunosuppression Omega 3 Acid Ethyl Esters Sancuso Acute Otitis Media Bredinin Carnitene Carnitine Deficiency Eyprotor Ferplex Fondaparinux Sodium Gaslon N Insomnia/Depression Iv Hodgkin's Disease Lateral Sclerosis Licensed In Pharmaceutical Products Mictonorm Nadroparin Calcium Natulan Self Developed And Generic Pharmaceutical Products Trittico Unidrox Urinary And Respiratory Tract Infections Yallaferon Zanidip Zingo Renal Transplantation

Home Page: www.leespharm.com

Building 20E
Sha Tin,
Hong Kong
Phone: 852 2314 1282


Officers

Name Title
Ms. Siu Fong Lee Chairman & Compliance Officer
Dr. Xiaoyi Li Ph.D. Founder, Senior Adviser & Non-Executive Director
Ms. Wanee Leelalertsuphakun MD, Chief Marketing & Sales Officer and Executive Director
Mr. Yiu Ming Chow Group CFO & Company Secretary
Mr. Yueshen Chen Director of Administration in China
Mr. Tsui Victor Kailok Group Chief Manufacturing Officer
Mr. Yuanjue Sun Chief Medical Officer
Mr. Zhongyu Jiao Group Deputy GM & GM of the Risk Control Centre

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 14
Price-to-Book MRQ: 0.3963
Price-to-Sales TTM: 0.072
IPO Date:
Fiscal Year End: December
Full Time Employees: 993
Back to stocks